MetaADEDB 2.0 @ LMMD
Terbinafine
(DOMXUEMWDBAQBQ-WEVVVXLNSA-N)
Structure
SMILES
CN(Cc1cccc2c1cccc2)C/C=C/C#CC(C)(C)C
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
D01AE15; D01BA02
Molecular Formula:
C21H25N
Molecular Weight:
291.430
Log P:
4.8773
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
0
TPSA:
3.24
CAS Number(s):
91161-71-6
Synonym(s)
1.
Terbinafine
2.
(E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride
3.
DA 5505
4.
Lamisil
5.
SF 86-327
6.
SF-86-327
7.
TDT-067
8.
Terbinafine Hydrochloride
9.
Terbinafine, (Z)-
10.
Terbinafine, (Z)-isomer
11.
SF 86 327
12.
SF 86327
13.
SF86327
14.
TDT 067
15.
TDT067
External Link(s)
MeSHD000077291
PubChem Compound1549008
BindingDB50018518
ChEBI9448
94705
CHEMBLCHEMBL822
DrugBankDB00857
DrugCentral2597
KEGGcpd:C08079
dr:D02375
Therapeutic Target DatabaseD01AYJ
ZINC1530981
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AgeusiaFAERS: 238
Canada Vigilance: 19
7475473CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
2Drug ineffectiveFAERS: 222
Canada Vigilance: 26
Canada Vigilance
US FAERS
3PruritusFAERS: 185
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
4Aspartate Aminotransferase IncreasedFAERS: 177
Canada Vigilance: 5
Canada Vigilance
US FAERS
5Alanine Aminotransferase IncreasedFAERS: 173
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
6DysgeusiaFAERS: 163
Canada Vigilance: 12
Canada Vigilance
OFFSIDES
SIDER
US FAERS
7NauseaFAERS: 153
Canada Vigilance: 10
10384922CTD
SIDER
Canada Vigilance
US FAERS
8FatigueFAERS: 126
Canada Vigilance: 10
Canada Vigilance
OFFSIDES
SIDER
US FAERS
9Blood creatine phosphokinase increasedFAERS: 125
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
10MalaiseFAERS: 124
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
11UrticariaFAERS: 124
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
12Weight decreasedFAERS: 124
Canada Vigilance: 11
Canada Vigilance
SIDER
US FAERS
13MyalgiaFAERS: 110
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
14Gamma-Glutamyltransferase IncreasedFAERS: 106
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
15ErythemaFAERS: 105
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
16ArthralgiaFAERS: 96
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
17AstheniaFAERS: 96
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
18Blood alkaline phosphatase increasedFAERS: 96
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
19PainFAERS: 95
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20HeadacheFAERS: 91
Canada Vigilance: 4
10384922
18378354
CTD
SIDER
Canada Vigilance
US FAERS
21DizzinessFAERS: 82
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
22HypersensitivityFAERS: 82
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
23jaundiceFAERS: 77
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
24RhabdomyolysisFAERS: 72OFFSIDES
SIDER
US FAERS
25Abdominal PainFAERS: 71
Canada Vigilance: 4
10384922CTD
SIDER
Canada Vigilance
US FAERS
26ChromaturiaFAERS: 71
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
27VomitingFAERS: 65
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
28Blood lactate dehydrogenase increasedFAERS: 62
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
29Product use in unapproved indicationFAERS: 61US FAERS
30AnosmiaFAERS: 53
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
31AnorexiaFAERS: 50OFFSIDES
SIDER
US FAERS
32AnxietyFAERS: 49SIDER
US FAERS
33White blood cell count decreasedFAERS: 48US FAERS
34Rash erythematousFAERS: 47
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
35HepatitisFAERS: 45
Canada Vigilance: 8
11508672
15614306
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
36Drug exposure during pregnancyFAERS: 43OFFSIDES
US FAERS
37Incorrect drug administration durationFAERS: 38US FAERS
38ChillsFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
39CholestasisFAERS: 34
Canada Vigilance: 1
15122001
15614306
CTD
SIDER
Canada Vigilance
US FAERS
40SwellingFAERS: 33US FAERS
41InfectionFAERS: 32
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
42LethargyFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Back PainFAERS: 30US FAERS
44Peripheral swellingFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
45InflammationFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
46PancytopeniaFAERS: 2811508672CTD
SIDER
US FAERS
47Burning sensationFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
48Drug effect incompleteFAERS: 27US FAERS
49Joint swellingFAERS: 27US FAERS
50PalpitationsFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
51General physical health deteriorationFAERS: 26US FAERS
52NeutropeniaFAERS: 26
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
53Therapeutic response unexpectedFAERS: 26OFFSIDES
US FAERS
54AlopeciaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
55Blood creatinine increasedFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Erythema MultiformeFAERS: 25
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
57LeukopeniaFAERS: 25
Canada Vigilance: 4
Canada Vigilance
US FAERS
58Product quality issueFAERS: 25US FAERS
59PsoriasisFAERS: 25OFFSIDES
SIDER
US FAERS
60Stevens-Johnson SyndromeFAERS: 2525811541CTD
OFFSIDES
SIDER
US FAERS
61Transaminases increasedFAERS: 25
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
62ArthritisFAERS: 24SIDER
US FAERS
63Feeling abnormalFAERS: 24SIDER
US FAERS
64Inappropriate schedule of drug administrationFAERS: 23US FAERS
65PneumoniaFAERS: 23US FAERS
66SyncopeFAERS: 23US FAERS
67Blood cholesterol increasedFAERS: 22US FAERS
68LymphadenopathyFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Skin reactionFAERS: 22US FAERS
70Chest PainFAERS: 21SIDER
US FAERS
71DeafnessFAERS: 21OFFSIDES
SIDER
US FAERS
72Drug administered at inappropriate siteFAERS: 21US FAERS
73DyspepsiaFAERS: 21
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
74ThrombocytopeniaFAERS: 21
Canada Vigilance: 1
17426078CTD
SIDER
Canada Vigilance
US FAERS
75Blood glucose increasedFAERS: 20US FAERS
76ConstipationFAERS: 20US FAERS
77PancreatitisFAERS: 20OFFSIDES
SIDER
US FAERS
78Pharyngolaryngeal PainFAERS: 20OFFSIDES
SIDER
US FAERS
79Urinary RetentionFAERS: 20US FAERS
80Erythema NodosumFAERS: 19OFFSIDES
US FAERS
81Lip swellingFAERS: 19US FAERS
82Pustular psoriasisFAERS: 19
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
83EpistaxisFAERS: 18US FAERS
84Neutrophil count decreasedFAERS: 18OFFSIDES
US FAERS
85Product use issueFAERS: 18US FAERS
86PurpuraFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Abdominal discomfortFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
88Depressed moodFAERS: 17OFFSIDES
US FAERS
89Lupus-like syndromeFAERS: 17OFFSIDES
US FAERS
90Ocular icterusFAERS: 17OFFSIDES
US FAERS
91ThirstFAERS: 17US FAERS
92TinnitusFAERS: 17
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
93Application site erythemaFAERS: 16
Canada Vigilance: 4
Canada Vigilance
US FAERS
94CellulitisFAERS: 16US FAERS
95Chest discomfortFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Incorrect dose administeredFAERS: 16US FAERS
97Skin lesionFAERS: 16OFFSIDES
US FAERS
98TremorFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
99Application site painFAERS: 15
Canada Vigilance: 4
Canada Vigilance
US FAERS
100Blood triglycerides increasedFAERS: 15OFFSIDES
US FAERS
101HepatomegalyFAERS: 1528108177CTD
US FAERS
102Eye painFAERS: 14OFFSIDES
US FAERS
103Oropharyngeal painFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
104Visual disturbanceFAERS: 14OFFSIDES
SIDER
US FAERS
105Drug ineffective for unapproved indicationFAERS: 13US FAERS
106Skin irritationFAERS: 13US FAERS
107VasculitisFAERS: 13SIDER
US FAERS
108Cytolytic hepatitisFAERS: 12OFFSIDES
US FAERS
109Disease recurrenceFAERS: 12OFFSIDES
US FAERS
110Drug administration errorFAERS: 12OFFSIDES
US FAERS
111EosinophiliaFAERS: 12SIDER
US FAERS
112Incorrect route of drug administrationFAERS: 12US FAERS
113Musculoskeletal stiffnessFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
114OverdoseFAERS: 12US FAERS
115PetechiaeFAERS: 12US FAERS
116Wrong technique in drug usage processFAERS: 12US FAERS
117DiscomfortFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
118DisorientationFAERS: 11US FAERS
119Dry skinFAERS: 11US FAERS
120DysuriaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
121GastroenteritisFAERS: 11US FAERS
122Limb discomfortFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
123Lymphocyte count decreasedFAERS: 11OFFSIDES
US FAERS
124OnychomycosisFAERS: 11
Canada Vigilance: 4

View details

CTD
Canada Vigilance
US FAERS
125RestlessnessFAERS: 11US FAERS
126SneezingFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Systemic lupus erythematosus rashFAERS: 11US FAERS
128VertigoFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
129Activities of daily living impairedFAERS: 10OFFSIDES
US FAERS
130AsthmaFAERS: 10OFFSIDES
US FAERS
131Autoimmune hepatitisFAERS: 10OFFSIDES
US FAERS
132Bilirubin conjugated increasedFAERS: 10OFFSIDES
US FAERS
133Cerebrovascular accidentFAERS: 10US FAERS
134Cholestatic liver injuryFAERS: 10US FAERS
135EczemaFAERS: 10OFFSIDES
SIDER
US FAERS
136Lipase increasedFAERS: 10US FAERS
137Myocardial InfarctionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
138Neck PainFAERS: 10US FAERS
139Tinea PedisFAERS: 10OFFSIDES
US FAERS
140Toxic Epidermal NecrolysisFAERS: 10SIDER
US FAERS
141Accidental exposure to productFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
142AngioedemaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
143Application site irritationFAERS: 9OFFSIDES
US FAERS
144Atrial FibrillationFAERS: 9US FAERS
145Blood amylase increasedFAERS: 9OFFSIDES
US FAERS
146Blood urea increasedFAERS: 9SIDER
US FAERS
147Bone painFAERS: 9US FAERS
148ColitisFAERS: 9US FAERS
149Diabetes MellitusFAERS: 9US FAERS
150Drug toxicityFAERS: 9US FAERS
151FlatulenceFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
152HepatotoxicityFAERS: 9US FAERS
153LymphomaFAERS: 9OFFSIDES
US FAERS
154MYELODYSPLASTIC SYNDROMEFAERS: 9US FAERS
155Myoglobin blood increasedFAERS: 9OFFSIDES
US FAERS
156NasopharyngitisFAERS: 9
Canada Vigilance: 1
18378354CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
157Protein urine presentFAERS: 9US FAERS
158Urinary tract infectionFAERS: 9US FAERS
159Wrong technique in product usage processFAERS: 9US FAERS
160AgranulocytosisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
161AscitesFAERS: 8US FAERS
162Blood albumin decreasedFAERS: 8US FAERS
163Concomitant disease aggravatedFAERS: 8OFFSIDES
US FAERS
164DiplopiaFAERS: 8OFFSIDES
US FAERS
165Exfoliative rashFAERS: 8OFFSIDES
US FAERS
166HypophagiaFAERS: 8US FAERS
167InfluenzaFAERS: 8SIDER
US FAERS
168Night sweatsFAERS: 8US FAERS
169OliguriaFAERS: 8US FAERS
170Product substitution issueFAERS: 8US FAERS
171ProteinuriaFAERS: 8US FAERS
172Quality of life decreasedFAERS: 8US FAERS
173Skin necrosisFAERS: 8US FAERS
174SomnolenceFAERS: 8US FAERS
175Deafness NeurosensoryFAERS: 7OFFSIDES
US FAERS
176DehydrationFAERS: 7US FAERS
177DermatitisFAERS: 7SIDER
US FAERS
178Drug effect delayedFAERS: 7US FAERS
179Electrocardiogram QT interval abnormalFAERS: 7US FAERS
180ErysipelasFAERS: 7OFFSIDES
US FAERS
181Expired product administeredFAERS: 7US FAERS
182GastritisFAERS: 7SIDER
US FAERS
183Hepatitis BFAERS: 7OFFSIDES
US FAERS
184Hepatitis CFAERS: 7OFFSIDES
US FAERS
185Intentional drug misuseFAERS: 7US FAERS
186LeukocytosisFAERS: 7US FAERS
187Lymphocyte stimulation test positiveFAERS: 7OFFSIDES
US FAERS
188Medication ErrorFAERS: 7US FAERS
189Musculoskeletal discomfortFAERS: 7OFFSIDES
SIDER
US FAERS
190MyositisFAERS: 7US FAERS
191NeuralgiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
192PhotodermatosisFAERS: 7OFFSIDES
SIDER
US FAERS
193PolyarthritisFAERS: 7US FAERS
194Purulent dischargeFAERS: 7OFFSIDES
US FAERS
195Saliva alteredFAERS: 7US FAERS
196ShockFAERS: 7US FAERS
197StressFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
198Visual ImpairmentFAERS: 7
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
199Angina PectorisFAERS: 6US FAERS
200Application site swellingFAERS: 6OFFSIDES
US FAERS
201ArthropathyFAERS: 6OFFSIDES
US FAERS
202Breast tendernessFAERS: 6US FAERS
203CataractFAERS: 6OFFSIDES
US FAERS
204CholecystitisFAERS: 6US FAERS
205Drug administered to patient of inappropriate ageFAERS: 6US FAERS
206Drug prescribing errorFAERS: 6US FAERS
207Emotional disorderFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
208Emotional distressFAERS: 6US FAERS
209Epidermal necrosisFAERS: 6US FAERS
210GlaucomaFAERS: 6OFFSIDES
US FAERS
211HypogeusiaFAERS: 6OFFSIDES
SIDER
US FAERS
212Low density lipoprotein increasedFAERS: 6US FAERS
213Mental impairmentFAERS: 6OFFSIDES
US FAERS
214Monocyte count increasedFAERS: 6US FAERS
215Neutrophil percentage decreasedFAERS: 6US FAERS
216Oral painFAERS: 6US FAERS
217Pain of skinFAERS: 6US FAERS
218PallorFAERS: 6US FAERS
219Platelet count abnormalFAERS: 6OFFSIDES
US FAERS
220PregnancyFAERS: 6US FAERS
221PresyncopeFAERS: 6US FAERS
222Renal ColicFAERS: 6OFFSIDES
US FAERS
223SepsisFAERS: 6US FAERS
224Sudden deathFAERS: 6US FAERS
225Throat irritationFAERS: 6US FAERS
226Vitreous opacitiesFAERS: 6US FAERS
227AbasiaFAERS: 5US FAERS
228Application site burnFAERS: 5
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
229Blood bilirubin abnormalFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
230Blood glucose decreasedFAERS: 5US FAERS
231Blood immunoglobulin G increasedFAERS: 5OFFSIDES
US FAERS
232Blood sodium decreasedFAERS: 5US FAERS
233CheilitisFAERS: 5US FAERS
234Disseminated Intravascular CoagulationFAERS: 5US FAERS
235Erectile dysfunctionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
236Expired drug administeredFAERS: 5US FAERS
237Eye irritationFAERS: 5US FAERS
238Feeling jitteryFAERS: 5US FAERS
239Genital dischargeFAERS: 5OFFSIDES
US FAERS
240Hepatic necrosisFAERS: 5US FAERS
241Impaired work abilityFAERS: 5OFFSIDES
US FAERS
242Joint stiffnessFAERS: 5US FAERS
243Lichen PlanusFAERS: 5US FAERS
244Lower respiratory tract infectionFAERS: 5US FAERS
245Lymphocyte percentage increasedFAERS: 5US FAERS
246LymphocytosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
247Memory impairmentFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
248MenorrhagiaFAERS: 5US FAERS
249Mucosal erosionFAERS: 5US FAERS
250No adverse eventFAERS: 5US FAERS
251Occupational exposure to productFAERS: 5US FAERS
252Oropharyngeal swellingFAERS: 5OFFSIDES
US FAERS
253PoisoningFAERS: 5US FAERS
254PolyuriaFAERS: 5US FAERS
255Product lot number issueFAERS: 5US FAERS
256Restless Legs SyndromeFAERS: 5US FAERS
257RetchingFAERS: 5US FAERS
258RhinitisFAERS: 5US FAERS
259SinusitisFAERS: 5US FAERS
260Skin UlcerFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
261Skin hypertrophyFAERS: 5US FAERS
262StomatitisFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
263Streptokinase antibody increasedFAERS: 5OFFSIDES
US FAERS
264SuperinfectionFAERS: 5US FAERS
265TachycardiaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
266Thrombocytopenic purpuraFAERS: 5US FAERS
267Tongue blisteringFAERS: 5US FAERS
268Transmission of drug via semenFAERS: 5OFFSIDES
US FAERS
269AcneFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
270Acute kidney injuryFAERS: 4US FAERS
271Adverse eventFAERS: 4US FAERS
272Alanine aminotransferase abnormalFAERS: 4US FAERS
273Aldolase increasedFAERS: 4OFFSIDES
US FAERS
274Alpha 2 globulin increasedFAERS: 4OFFSIDES
US FAERS
275Application site pruritusFAERS: 4US FAERS
276Biliary ColicFAERS: 4US FAERS
277Biopsy liver abnormalFAERS: 4OFFSIDES
US FAERS
278BiopsyFAERS: 4US FAERS
279Blood count abnormalFAERS: 4US FAERS
280Blood creatine phosphokinase MB increasedFAERS: 4OFFSIDES
US FAERS
281Blood potassium decreasedFAERS: 4US FAERS
282Blood potassium increasedFAERS: 4US FAERS
283Blood urine presentFAERS: 4US FAERS
284CholangitisFAERS: 4US FAERS
285CholelithiasisFAERS: 4US FAERS
286ColectomyFAERS: 4US FAERS
287Creatinine renal clearance decreasedFAERS: 4US FAERS
288CryingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
289DeliriumFAERS: 4US FAERS
290DementiaFAERS: 4US FAERS
291Device related infectionFAERS: 4US FAERS
292DysarthriaFAERS: 4US FAERS
293Enzyme InhibitionFAERS: 4US FAERS
294EpilepsyFAERS: 4OFFSIDES
US FAERS
295Flank PainFAERS: 4OFFSIDES
US FAERS
296GlossitisFAERS: 4OFFSIDES
US FAERS
297HepatosplenomegalyFAERS: 4US FAERS
298HypotensionFAERS: 4US FAERS
299HypothyroidismFAERS: 4US FAERS
300Impaired driving abilityFAERS: 4US FAERS
301Intentional product use issueFAERS: 4US FAERS
302IridocyclitisFAERS: 4OFFSIDES
US FAERS
303Lactation DisorderFAERS: 4OFFSIDES
US FAERS
304LymphopeniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
305MetrorrhagiaFAERS: 4US FAERS
306Multiple sclerosis relapseFAERS: 4US FAERS
307MyoglobinaemiaFAERS: 4OFFSIDES
US FAERS
308OnychalgiaFAERS: 4US FAERS
309PapuleFAERS: 4US FAERS
310Pathogen resistanceFAERS: 4US FAERS
311Pityriasis RoseaFAERS: 4US FAERS
312Poor quality sleepFAERS: 4US FAERS
313Product administered at inappropriate siteFAERS: 4US FAERS
314Product complaintFAERS: 4US FAERS
315Pulmonary FibrosisFAERS: 4US FAERS
316Respiratory FailureFAERS: 4US FAERS
317Rheumatoid factor increasedFAERS: 4OFFSIDES
US FAERS
318Skin tightnessFAERS: 4US FAERS
319Solar urticariaFAERS: 4OFFSIDES
US FAERS
320SplenectomyFAERS: 4OFFSIDES
US FAERS
321Stroke in evolutionFAERS: 4OFFSIDES
US FAERS
322Subcutaneous AbscessFAERS: 4US FAERS
323Temporal ArteritisFAERS: 4OFFSIDES
US FAERS
324Thermal burnFAERS: 4US FAERS
325Toxicity to various agentsFAERS: 4US FAERS
326TrichophytosisFAERS: 4US FAERS
327Unevaluable eventFAERS: 4US FAERS
328VIIth nerve paralysisFAERS: 4US FAERS
329VitiligoFAERS: 4US FAERS
330White blood cell agglutination presentFAERS: 4OFFSIDES
US FAERS
331Abnormal weight gainFAERS: 3US FAERS
332Accidental exposureFAERS: 3US FAERS
333Activated partial thromboplastin time shortenedFAERS: 3OFFSIDES
US FAERS
334Alopecia totalisFAERS: 3OFFSIDES
US FAERS
335Ammonia increasedFAERS: 3US FAERS
336AmnesiaFAERS: 3US FAERS
337Anal abscessFAERS: 3US FAERS
338AngerFAERS: 3US FAERS
339Antiphospholipid antibodies positiveFAERS: 3US FAERS
340Application site exfoliationFAERS: 3US FAERS
341AsthenopiaFAERS: 3US FAERS
342Atrioventricular BlockFAERS: 3US FAERS
343BlindnessFAERS: 3US FAERS
344Blood blisterFAERS: 3OFFSIDES
US FAERS
345Blood cholinesterase decreasedFAERS: 3OFFSIDES
US FAERS
346Blood cholinesterase increasedFAERS: 3US FAERS
347Blood creatinine decreasedFAERS: 3OFFSIDES
US FAERS
348Blood immunoglobulin A increasedFAERS: 3US FAERS
349Blood iron increasedFAERS: 3OFFSIDES
US FAERS
350Bone marrow depressionFAERS: 3OFFSIDES
US FAERS
351BronchitisFAERS: 3OFFSIDES
US FAERS
352CachexiaFAERS: 3US FAERS
353Cardiac TamponadeFAERS: 3US FAERS
354Chemical burn of skinFAERS: 3OFFSIDES
US FAERS
355ChokingFAERS: 3US FAERS
356Circumstance or information capable of leading to medication errorFAERS: 3OFFSIDES
US FAERS
357Cold sweatFAERS: 3US FAERS
358Complications of maternal exposure to therapeutic drugsFAERS: 3OFFSIDES
US FAERS
359Depressed Level of ConsciousnessFAERS: 3US FAERS
360DermatomyositisFAERS: 3US FAERS
361Diabetes mellitus inadequate controlFAERS: 3US FAERS
362Drug dispensing errorFAERS: 3US FAERS
363Drug effective for unapproved indicationFAERS: 3US FAERS
364Drug resistanceFAERS: 3US FAERS
365EcchymosisFAERS: 3US FAERS
366EndocarditisFAERS: 3OFFSIDES
US FAERS
367Endothelial dysfunctionFAERS: 3OFFSIDES
US FAERS
368EnteritisFAERS: 3US FAERS
369Erythrodermic psoriasisFAERS: 3OFFSIDES
US FAERS
370Eye RednessFAERS: 3US FAERS
371FractureFAERS: 3US FAERS
372Gingival erythemaFAERS: 3US FAERS
373GingivitisFAERS: 3US FAERS
374GranulomaFAERS: 3OFFSIDES
US FAERS
375HypokinesiaFAERS: 3US FAERS
376ImmobileFAERS: 3US FAERS
377Inability to afford medicationFAERS: 3US FAERS
378InfarctionFAERS: 3US FAERS
379Intentional product misuseFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
380Leukocytoclastic vasculitisFAERS: 3US FAERS
381Lymphocyte count increasedFAERS: 3US FAERS
382Markedly reduced dietary intakeFAERS: 3US FAERS
383Maternal exposure during pregnancyFAERS: 3US FAERS
384Musculoskeletal PainFAERS: 3US FAERS
385Musculoskeletal chest painFAERS: 3OFFSIDES
US FAERS
386NephrectomyFAERS: 3OFFSIDES
US FAERS
387NephrolithiasisFAERS: 3OFFSIDES
US FAERS
388NervousnessFAERS: 3US FAERS
389Neutrophil percentage increasedFAERS: 3US FAERS
390OnychoclasisFAERS: 3US FAERS
391Oropharyngeal blisteringFAERS: 3OFFSIDES
US FAERS
392Paradoxical drug reactionFAERS: 3US FAERS
393PolydipsiaFAERS: 3US FAERS
394PolyneuropathyFAERS: 3US FAERS
395Poor quality drug administeredFAERS: 3US FAERS
396Productive CoughFAERS: 3OFFSIDES
US FAERS
397PrurigoFAERS: 3US FAERS
398RalesFAERS: 3US FAERS
399Renal painFAERS: 3US FAERS
400Reticulocyte count increasedFAERS: 3OFFSIDES
US FAERS
401Retinal DegenerationFAERS: 3OFFSIDES
US FAERS
402Retinal DetachmentFAERS: 3US FAERS
403Retinal Vein OcclusionFAERS: 3OFFSIDES
US FAERS
404SciaticaFAERS: 3US FAERS
405Serum SicknessFAERS: 3OFFSIDES
SIDER
US FAERS
406Shoulder PainFAERS: 3OFFSIDES
US FAERS
407Skin dystrophyFAERS: 3OFFSIDES
US FAERS
408Skin test positiveFAERS: 3US FAERS
409Soft Tissue InfectionFAERS: 3US FAERS
410StridorFAERS: 3OFFSIDES
US FAERS
411SunburnFAERS: 3US FAERS
412Therapeutic product contaminationFAERS: 3US FAERS
413Tongue discomfortFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
414Tooth ExtractionFAERS: 3US FAERS
415Venous InjuryFAERS: 3OFFSIDES
US FAERS
416Vitreous floatersFAERS: 3US FAERS
417WheezingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
418Wound DebridementFAERS: 3OFFSIDES
US FAERS
419prostatitisFAERS: 3US FAERS
420Abdominal tendernessFAERS: 2US FAERS
421AbscessFAERS: 2US FAERS
422Acute myocardial infarctionFAERS: 2OFFSIDES
US FAERS
423AgitationFAERS: 2US FAERS
424Alpha hydroxybutyrate dehydrogenase increasedFAERS: 2US FAERS
425AngioplastyFAERS: 2US FAERS
426Anti-SS-A antibody positiveFAERS: 2OFFSIDES
US FAERS
427Application site discomfortFAERS: 2US FAERS
428Application site inflammationFAERS: 2US FAERS
429Application site reactionFAERS: 2US FAERS
430Application site ulcerFAERS: 2US FAERS
431Application site vesiclesFAERS: 2US FAERS
432Application site warmthFAERS: 2US FAERS
433BedriddenFAERS: 2US FAERS
434Biliary dilatationFAERS: 2OFFSIDES
US FAERS
435Biopsy bone marrow abnormalFAERS: 2OFFSIDES
US FAERS
436Blast cells presentFAERS: 2OFFSIDES
US FAERS
437BlepharitisFAERS: 2US FAERS
438Blood bilirubin unconjugated increasedFAERS: 2OFFSIDES
US FAERS
439Blood creatine phosphokinase MMFAERS: 2US FAERS
440Blood creatinine abnormalFAERS: 2US FAERS
441Blood immunoglobulin E decreasedFAERS: 2US FAERS
442Blood immunoglobulin E increasedFAERS: 2US FAERS
443Blood iron decreasedFAERS: 2OFFSIDES
US FAERS
444Blood phosphorus decreasedFAERS: 2US FAERS
445Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
446Blood uric acid decreasedFAERS: 2OFFSIDES
US FAERS
447Bone density decreasedFAERS: 2US FAERS
448BronchospasmFAERS: 2US FAERS
449Butterfly rashFAERS: 2US FAERS
450Callus formation delayedFAERS: 2OFFSIDES
US FAERS
451Carbohydrate antigen 19-9 increasedFAERS: 2US FAERS
452Cataract operationFAERS: 2OFFSIDES
US FAERS
453Cell DeathFAERS: 2US FAERS
454Concomitant disease progressionFAERS: 2US FAERS
455ConjunctivitisFAERS: 2US FAERS
456Corneal lesionFAERS: 2US FAERS
457Cytomegalovirus antibody positiveFAERS: 2OFFSIDES
US FAERS
458Deep Vein ThrombosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
459DermatophytosisFAERS: 2OFFSIDES
US FAERS
460Drug DependenceFAERS: 2US FAERS
461Drug exposure before pregnancyFAERS: 2OFFSIDES
US FAERS
462Duodenal UlcerFAERS: 2US FAERS
463Economic problemFAERS: 2OFFSIDES
US FAERS
464EmbolismFAERS: 2OFFSIDES
US FAERS
465ExcoriationFAERS: 2US FAERS
466Exposure during breast feedingFAERS: 2US FAERS
467Eye InfectionFAERS: 2OFFSIDES
US FAERS
468Facial PainFAERS: 2US FAERS
469Facial ParesisFAERS: 2US FAERS
470Familial Mediterranean FeverFAERS: 2OFFSIDES
US FAERS
471Feeding disorder neonatalFAERS: 2OFFSIDES
US FAERS
472FlushingFAERS: 2US FAERS
473FormicationFAERS: 2OFFSIDES
US FAERS
474Gamma-glutamyltransferase decreasedFAERS: 2US FAERS
475Gastric ulcerFAERS: 2US FAERS
476General physical condition abnormalFAERS: 2US FAERS
477GoutFAERS: 2OFFSIDES
US FAERS
478Growing painsFAERS: 2US FAERS
479Guillain-Barre SyndromeFAERS: 2US FAERS
480Head discomfortFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
481HemiparesisFAERS: 2OFFSIDES
US FAERS
482Hepatic EncephalopathyFAERS: 2US FAERS
483Hepatitis A antibody positiveFAERS: 2US FAERS
484HerniaFAERS: 2OFFSIDES
US FAERS
485HungerFAERS: 2US FAERS
486Idiosyncratic drug reactionFAERS: 2US FAERS
487Increased tendency to bruiseFAERS: 2US FAERS
488InfertilityFAERS: 2OFFSIDES
US FAERS
489Light chain analysis increasedFAERS: 2US FAERS
490Lyme DiseaseFAERS: 2OFFSIDES
US FAERS
491Lymphocyte percentage decreasedFAERS: 2US FAERS
492Lymphocyte stimulation test negativeFAERS: 2OFFSIDES
US FAERS
493MalabsorptionFAERS: 2US FAERS
494Malignant neoplasm progressionFAERS: 2US FAERS
495Medial Tibial Stress SyndromeFAERS: 2US FAERS
496Megakaryocytes decreasedFAERS: 2OFFSIDES
US FAERS
497Megaloblasts increasedFAERS: 2OFFSIDES
US FAERS
498Mental status changesFAERS: 2US FAERS
499Middle insomniaFAERS: 2US FAERS
500Monocyte morphology abnormalFAERS: 2OFFSIDES
US FAERS
501Mycosis FungoidesFAERS: 2OFFSIDES
US FAERS
502Myoglobin urine presentFAERS: 2OFFSIDES
US FAERS
503Nail InfectionFAERS: 2US FAERS
504Nasal discomfortFAERS: 2OFFSIDES
US FAERS
505Open woundFAERS: 2OFFSIDES
US FAERS
506OsteomyelitisFAERS: 2US FAERS
507OsteoporosisFAERS: 2US FAERS
508Pancreatic carcinomaFAERS: 2US FAERS
509PemphigusFAERS: 2US FAERS
510Pericardial effusionFAERS: 2US FAERS
511Peripheral nerve lesionFAERS: 2OFFSIDES
US FAERS
512Perivascular dermatitisFAERS: 2US FAERS
513Pharmaceutical product counterfeitFAERS: 2OFFSIDES
US FAERS
514PhlebitisFAERS: 2US FAERS
515PhotophobiaFAERS: 2US FAERS
516PlasmapheresisFAERS: 2OFFSIDES
US FAERS
517PleurisyFAERS: 2US FAERS
518Prescription drug used without a prescriptionFAERS: 2US FAERS
519Prothrombin time ratioFAERS: 2US FAERS
520PseudohyperkalaemiaFAERS: 2OFFSIDES
US FAERS
521Pulmonary EmbolismFAERS: 2US FAERS
522Pulmonary congestionFAERS: 2US FAERS
523Rash scalyFAERS: 2US FAERS
524Reaction to preservativesFAERS: 2OFFSIDES
US FAERS
525Respiratory distressFAERS: 2US FAERS
526Secretion dischargeFAERS: 2OFFSIDES
US FAERS
527Semen abnormalFAERS: 2OFFSIDES
US FAERS
528Sjogren's SyndromeFAERS: 2OFFSIDES
US FAERS
529Skin lacerationFAERS: 2US FAERS
530SplenomegalyFAERS: 2US FAERS
531Subcorneal pustular dermatosisFAERS: 2OFFSIDES
US FAERS
532Suicide attemptFAERS: 2US FAERS
533Suspected counterfeit productFAERS: 2US FAERS
534Symmetrical drug-related intertriginous and flexural exanthemaFAERS: 2US FAERS
535Temperature regulation disorderFAERS: 2OFFSIDES
US FAERS
536TensionFAERS: 2US FAERS
537Thirst decreasedFAERS: 2OFFSIDES
US FAERS
538ThrombosisFAERS: 2US FAERS
539ThyroiditisFAERS: 2US FAERS
540Tinea crurisFAERS: 2OFFSIDES
US FAERS
541Tongue eruptionFAERS: 2OFFSIDES
US FAERS
542TonsillitisFAERS: 2OFFSIDES
US FAERS
543Transferrin increasedFAERS: 2OFFSIDES
US FAERS
544Unintentional use for unapproved indicationFAERS: 2US FAERS
545Unresponsive to stimuliFAERS: 2US FAERS
546Urinary sediment abnormalFAERS: 2OFFSIDES
US FAERS
547Urine output increasedFAERS: 2US FAERS
548Vascular occlusionFAERS: 2US FAERS
549Viral load decreasedFAERS: 2OFFSIDES
US FAERS
550Vulvovaginal drynessFAERS: 2US FAERS
551Wound necrosisFAERS: 2US FAERS
552nervous system disorderFAERS: 2SIDER
US FAERS
553Abdominal rigidityFAERS: 1US FAERS
554Accidental exposure to product by childFAERS: 1US FAERS
555Actinic keratosisFAERS: 1US FAERS
556Activated Protein C ResistanceFAERS: 1US FAERS
557Acute sinusitisFAERS: 1US FAERS
558Acute tonsillitisFAERS: 1US FAERS
559AllodyniaFAERS: 1US FAERS
560Amyotrophic Lateral SclerosisFAERS: 1US FAERS
561Anal erosionFAERS: 1US FAERS
562Anaphylactic shockFAERS: 1SIDER
US FAERS
563Anastomotic ulcerFAERS: 1US FAERS
564AnencephalyFAERS: 1US FAERS
565AnhedoniaFAERS: 1US FAERS
566Anti-SS-B antibody positiveFAERS: 1US FAERS
567AphagiaFAERS: 1US FAERS
568AphoniaFAERS: 1US FAERS
569Aphthous StomatitisFAERS: 1US FAERS
570Apparent deathFAERS: 1US FAERS
571Application site acneFAERS: 1US FAERS
572Application site alopeciaFAERS: 1US FAERS
573Application site drynessFAERS: 1US FAERS
574Application site erosionFAERS: 1US FAERS
575Application site hypersensitivityFAERS: 1US FAERS
576Application site rashFAERS: 1US FAERS
577ArteriosclerosisFAERS: 1US FAERS
578Arthropod biteFAERS: 1OFFSIDES
US FAERS
579AsbestosisFAERS: 1OFFSIDES
US FAERS
580Aspartate aminotransferase decreasedFAERS: 1US FAERS
581AsphyxiaFAERS: 1US FAERS
582Atrial hypertrophyFAERS: 1US FAERS
583Autoantibody positiveFAERS: 1OFFSIDES
US FAERS
584Autoimmune thyroiditisFAERS: 1US FAERS
585Autonomic nervous system imbalanceFAERS: 1US FAERS
586AzoospermiaFAERS: 1US FAERS
587Bacterial culture positiveFAERS: 1US FAERS
588Band neutrophil percentage decreasedFAERS: 1OFFSIDES
US FAERS
589Bile Duct StenosisFAERS: 1US FAERS
590Biopsy bladder normalFAERS: 1US FAERS
591Biopsy skin abnormalFAERS: 1US FAERS
592Bladder prolapseFAERS: 1US FAERS
593BlepharospasmFAERS: 1US FAERS
594Blood pressure fluctuationFAERS: 1US FAERS
595Blood sodium increasedFAERS: 1US FAERS
596Body temperature fluctuationFAERS: 1US FAERS
597Bone marrow necrosisFAERS: 1US FAERS
598Bowel movement irregularityFAERS: 1US FAERS
599Bronchial ObstructionFAERS: 1US FAERS
600BronchopneumoniaFAERS: 1US FAERS
601Buccal mucosal rougheningFAERS: 1OFFSIDES
US FAERS
602Budd-Chiari SyndromeFAERS: 1US FAERS
603Calcium deficiencyFAERS: 1US FAERS
604CandidiasisFAERS: 1US FAERS
605Cardiac FlutterFAERS: 1OFFSIDES
US FAERS
606CardiomegalyFAERS: 1US FAERS
607Carotid artery occlusionFAERS: 1US FAERS
608Carpal Tunnel SyndromeFAERS: 1US FAERS
609CatatoniaFAERS: 1US FAERS
610Catheter placementFAERS: 1OFFSIDES
US FAERS
611Caustic injuryFAERS: 1US FAERS
612Cerebral hypoperfusionFAERS: 1US FAERS
613Chemical injuryFAERS: 1US FAERS
614CholedochoenterostomyFAERS: 1OFFSIDES
US FAERS
615CholelithotomyFAERS: 1US FAERS
616Coagulation factor X level decreasedFAERS: 1US FAERS
617Coital bleedingFAERS: 1OFFSIDES
US FAERS
618Collagen-vascular diseaseFAERS: 1US FAERS
619Complement factor increasedFAERS: 1US FAERS
620Completed SuicideFAERS: 1US FAERS
621Congenital heart valve disorderFAERS: 1US FAERS
622Conjunctival ulcerFAERS: 1US FAERS
623Contact lens complicationFAERS: 1US FAERS
624Corneal erosionFAERS: 1US FAERS
625Coronary artery insufficiencyFAERS: 1US FAERS
626CyanosisFAERS: 1US FAERS
627CystitisFAERS: 1US FAERS
628Dacryostenosis acquiredFAERS: 1US FAERS
629DeformityFAERS: 1US FAERS
630DemyelinationFAERS: 1US FAERS
631Device material issueFAERS: 1US FAERS
632Differential white blood cell count abnormalFAERS: 1US FAERS
633DisabilityFAERS: 1US FAERS
634DissociationFAERS: 1US FAERS
635Drug abuserFAERS: 1US FAERS
636Drug screen positiveFAERS: 1US FAERS
637DysphoniaFAERS: 1US FAERS
638Early satietyFAERS: 1US FAERS
639Eating disorder symptomFAERS: 1US FAERS
640Eczema weepingFAERS: 1OFFSIDES
US FAERS
641Educational problemFAERS: 1US FAERS
642Electrocardiogram abnormalFAERS: 1US FAERS
643Electrolyte imbalanceFAERS: 1US FAERS
644Elevated moodFAERS: 1US FAERS
645Eosinophilic PneumoniaFAERS: 1OFFSIDES
US FAERS
646Eosinophilic colitisFAERS: 1US FAERS
647EpicondylitisFAERS: 1US FAERS
648Epstein-Barr virus antibody positiveFAERS: 1OFFSIDES
US FAERS
649EructationFAERS: 1SIDER
US FAERS
650Exercise capacity decreasedFAERS: 1US FAERS
651Extensive swelling of vaccinated limbFAERS: 1US FAERS
652Eye allergyFAERS: 1US FAERS
653Eye laser surgeryFAERS: 1US FAERS
654Eyelid exfoliationFAERS: 1US FAERS
655Feeling ColdFAERS: 1US FAERS
656Feeling of body temperature changeFAERS: 1US FAERS
657Fibrin D dimer increasedFAERS: 1US FAERS
658FibromyalgiaFAERS: 1US FAERS
659FibrosisFAERS: 1US FAERS
660Food AllergyFAERS: 1US FAERS
661FrustrationFAERS: 1US FAERS
662Gastrointestinal carcinomaFAERS: 1US FAERS
663Gastrointestinal erosionFAERS: 1US FAERS
664Gastrointestinal inflammationFAERS: 1US FAERS
665Gastrointestinal motility disorderFAERS: 1US FAERS
666Genital discomfortFAERS: 1US FAERS
667Gingival RecessionFAERS: 1US FAERS
668HIV antibody positiveFAERS: 1US FAERS
669Hepatic siderosisFAERS: 1US FAERS
670Hepatic vein stenosisFAERS: 1US FAERS
671Hepatitis AFAERS: 1OFFSIDES
US FAERS
672Hepatitis B core antigen positiveFAERS: 1US FAERS
673Hepatitis C antibody positiveFAERS: 1OFFSIDES
US FAERS
674Hepatitis C positiveFAERS: 1US FAERS
675Hepatitis C virus test positiveFAERS: 1US FAERS
676Hormone level abnormalFAERS: 1US FAERS
677HyperkeratosisFAERS: 1OFFSIDES
US FAERS
678HypersomniaFAERS: 1US FAERS
679Hypertensive crisisFAERS: 1US FAERS
680Impaired gastric emptyingFAERS: 1US FAERS
681Impaired self-careFAERS: 1US FAERS
682ImpetigoFAERS: 1US FAERS
683Inappropriate schedule of product administrationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
684IncontinenceFAERS: 1US FAERS
685Incorrect dose administered by deviceFAERS: 1US FAERS
686Incorrect product administration durationFAERS: 1US FAERS
687Incorrect product formulation administeredFAERS: 1US FAERS
688Infection reactivationFAERS: 1US FAERS
689Injection site warmthFAERS: 1US FAERS
690Intentional self-injuryFAERS: 1US FAERS
691Intercepted drug administration errorFAERS: 1US FAERS
692Intercepted product administration errorFAERS: 1US FAERS
693Intestinal villi atrophyFAERS: 1US FAERS
694Irregular sleep wake rhythm disorderFAERS: 1US FAERS
695Juvenile arthritisFAERS: 1US FAERS
696KeratitisFAERS: 1US FAERS
697LacerationFAERS: 1US FAERS
698Lip exfoliationFAERS: 1US FAERS
699Livedo ReticularisFAERS: 1US FAERS
700Liver AbscessFAERS: 1US FAERS
701Loose toothFAERS: 1US FAERS
702LymphadenitisFAERS: 1US FAERS
703LymphangitisFAERS: 1OFFSIDES
US FAERS
704Lymphocytic infiltrationFAERS: 1US FAERS
705Macular degenerationFAERS: 1US FAERS
706MaculeFAERS: 1US FAERS
707Mechanical ventilationFAERS: 1OFFSIDES
US FAERS
708MeningismFAERS: 1US FAERS
709MenopauseFAERS: 1US FAERS
710MicroalbuminuriaFAERS: 1US FAERS
711MiliariaFAERS: 1US FAERS
712Mixed Connective Tissue DiseaseFAERS: 1US FAERS
713Monocyte count decreasedFAERS: 1US FAERS
714Monocyte percentage increasedFAERS: 1OFFSIDES
US FAERS
715MonocytosisFAERS: 1US FAERS
716Mood swingsFAERS: 1US FAERS
717Mouth swellingFAERS: 1US FAERS
718Multi-organ disorderFAERS: 1US FAERS
719Multiple SclerosisFAERS: 1US FAERS
720Muscle CrampFAERS: 1US FAERS
721Muscle FatigueFAERS: 1US FAERS
722Myasthenia GravisFAERS: 1US FAERS
723Mycotic allergyFAERS: 1US FAERS
724MyokymiaFAERS: 1US FAERS
725Nail necrosisFAERS: 1US FAERS
726NephritisFAERS: 1US FAERS
727Nephrotic SyndromeFAERS: 1OFFSIDES
US FAERS
728Nerve injuryFAERS: 1US FAERS
729NeuropathyFAERS: 1US FAERS
730Neutropenic sepsisFAERS: 1US FAERS
731NoduleFAERS: 1US FAERS
732Nonspecific reactionFAERS: 1US FAERS
733Nuchal RigidityFAERS: 1US FAERS
734ObesityFAERS: 1US FAERS
735Obsessive thoughtsFAERS: 1US FAERS
736Obsessive-Compulsive DisorderFAERS: 1US FAERS
737Ocular discomfortFAERS: 1US FAERS
738Oculomucocutaneous syndromeFAERS: 1US FAERS
739Optic AtrophyFAERS: 1US FAERS
740Optic NeuritisFAERS: 1OFFSIDES
US FAERS
741OsteitisFAERS: 1US FAERS
742OsteopeniaFAERS: 1OFFSIDES
US FAERS
743Otitis MediaFAERS: 1US FAERS
744Overlap syndromeFAERS: 1US FAERS
745Pancreas lipomatosisFAERS: 1US FAERS
746Pancreatic CystFAERS: 1US FAERS
747Pancreatic InsufficiencyFAERS: 1OFFSIDES
US FAERS
748Pancreatic enzymes abnormalFAERS: 1US FAERS
749Panic DisorderFAERS: 1US FAERS
750Parvovirus B19 serology positiveFAERS: 1US FAERS
751Pelvic PainFAERS: 1US FAERS
752Penile blisterFAERS: 1US FAERS
753Penile erythemaFAERS: 1US FAERS
754Perforated ulcerFAERS: 1US FAERS
755Peritoneal DialysisFAERS: 1US FAERS
756Pharmaceutical product complaintFAERS: 1US FAERS
757Polyarteritis NodosaFAERS: 1US FAERS
758Polymyalgia RheumaticaFAERS: 1US FAERS
759PolymyositisFAERS: 1US FAERS
760Portal HypertensionFAERS: 1US FAERS
761Post procedural complicationFAERS: 1US FAERS
762Post-Traumatic Stress DisorderFAERS: 1US FAERS
763Pre-EclampsiaFAERS: 1US FAERS
764Precocious PubertyFAERS: 1US FAERS
765Product counterfeitFAERS: 1US FAERS
766Product label issueFAERS: 1US FAERS
767Product primary packaging issueFAERS: 1US FAERS
768Prostate examination abnormalFAERS: 1US FAERS
769Protein total decreasedFAERS: 1US FAERS
770Protein total increasedFAERS: 1OFFSIDES
US FAERS
771PseudocystFAERS: 1US FAERS
772Pupillary light reflex tests abnormalFAERS: 1US FAERS
773PurulenceFAERS: 1US FAERS
774PyelonephritisFAERS: 1US FAERS
775Q FeverFAERS: 1US FAERS
776Reaction to drug excipientsFAERS: 1US FAERS
777Rebound effectFAERS: 1US FAERS
778Renal vasculitisFAERS: 1US FAERS
779Respiratory arrestFAERS: 1US FAERS
780Respiratory tract infection fungalFAERS: 1US FAERS
781Retinal artery embolismFAERS: 1US FAERS
782Retinal exudatesFAERS: 1US FAERS
783Retinal infarctionFAERS: 1OFFSIDES
US FAERS
784RhinalgiaFAERS: 1US FAERS
785RhonchiFAERS: 1OFFSIDES
US FAERS
786Right ventricular failureFAERS: 1US FAERS
787ScabFAERS: 1US FAERS
788Scedosporium infectionFAERS: 1OFFSIDES
US FAERS
789ScreamingFAERS: 1US FAERS
790Sense of oppressionFAERS: 1US FAERS
791Septal panniculitisFAERS: 1US FAERS
792Septic ShockFAERS: 1US FAERS
793Sexual DysfunctionFAERS: 1US FAERS
794Sick Building SyndromeFAERS: 1US FAERS
795Sinus bradycardiaFAERS: 1OFFSIDES
US FAERS
796Sinus headacheFAERS: 1US FAERS
797Skin WrinklingFAERS: 1US FAERS
798Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
799SomnambulismFAERS: 1US FAERS
800Squamous cell carcinomaFAERS: 1US FAERS
801Subcutaneous noduleFAERS: 1US FAERS
802SubileusFAERS: 1OFFSIDES
US FAERS
803Supraventricular tachycardiaFAERS: 1US FAERS
804SynovitisFAERS: 1OFFSIDES
US FAERS
805Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
806Tension HeadacheFAERS: 1US FAERS
807Therapy cessationFAERS: 1US FAERS
808Therapy non-responderFAERS: 1US FAERS
809ThromboembolectomyFAERS: 1US FAERS
810Tinea CapitisFAERS: 118378354CTD
US FAERS
811Tongue exfoliationFAERS: 1US FAERS
812Tongue spasmFAERS: 1US FAERS
813Tooth LossFAERS: 1US FAERS
814Total cholesterol/HDL ratio increasedFAERS: 1US FAERS
815Toxic Optic NeuropathyFAERS: 1US FAERS
816Trisomy 21FAERS: 1US FAERS
817Tryptase increasedFAERS: 1US FAERS
818Tumour haemorrhageFAERS: 1US FAERS
819Tympanic Membrane PerforationFAERS: 1OFFSIDES
US FAERS
820Ultrasound liver abnormalFAERS: 1US FAERS
821Upper respiratory tract inflammationFAERS: 1US FAERS
822Urinary occult blood positiveFAERS: 1US FAERS
823Urine flow decreasedFAERS: 1US FAERS
824Urine ketone body presentFAERS: 1US FAERS
825UveitisFAERS: 1US FAERS
826Varicella Zoster Virus InfectionFAERS: 1US FAERS
827Venous angioma of brainFAERS: 1US FAERS
828Ventricular DysfunctionFAERS: 1US FAERS
829Vitreous DetachmentFAERS: 1OFFSIDES
US FAERS
830VitritisFAERS: 1US FAERS
831Vulvovaginal discomfortFAERS: 1US FAERS
832Vulvovaginal mycotic infectionFAERS: 1OFFSIDES
US FAERS
833Vulvovaginal pruritusFAERS: 1US FAERS
834White blood cell count abnormalFAERS: 1US FAERS
835Wrong drug administeredFAERS: 1US FAERS
836Wrong product administeredFAERS: 1US FAERS
837X-ray limb abnormalFAERS: 1US FAERS
838diagnostic procedureFAERS: 1US FAERS
839effusionFAERS: 1US FAERS
840keratoacanthomaFAERS: 1US FAERS
841treatment failureFAERS: 1US FAERS
842Abdominal CrampsSIDER
843Abdominal symptomOFFSIDES
844Acid refluxOFFSIDES
845Acute glomerulonephritisOFFSIDES
846Alcohol withdrawal syndromeOFFSIDES
847Anaphylactoid ReactionSIDER
848AnhidrosisOFFSIDES
849Antasthmatic drug level above therapeuticOFFSIDES
850ApathyOFFSIDES
851AtelectasisOFFSIDES
852AutomatismOFFSIDES
853Back disorderOFFSIDES
854BalanoposthitisCanada Vigilance: 1Canada Vigilance
855Band neutrophil percentage increasedOFFSIDES
856Benign Prostatic HyperplasiaOFFSIDES
857BicytopeniaOFFSIDES
858Biopsy bone abnormalOFFSIDES
859Bladder discomfortCanada Vigilance: 1Canada Vigilance
860Blood GlucoseOFFSIDES
861Blood albumin abnormalCanada Vigilance: 1Canada Vigilance
862Blood albumin increasedOFFSIDES
863Blood and lymphatic system disordersSIDER
864Blood cannabinoidsOFFSIDES
865Blood cholesterolOFFSIDES
866Blood immunoglobulin EOFFSIDES
867Blood iron abnormalOFFSIDES
868Blood pressure ambulatory decreasedOFFSIDES
869Bradycardia24894748CTD
870Breast discomfortOFFSIDES
871Bullous eruptionSIDER
872BunionOFFSIDES
873Candida serology positiveOFFSIDES
874Candidiasis of vaginaOFFSIDES
875Cardiac HypertrophyOFFSIDES
876Cardiac function test abnormalOFFSIDES
877Ceruloplasmin decreasedOFFSIDES
878Chemical and Drug Induced Liver Injury

View details

CTD
879Chest wall painOFFSIDES
880CholangiolitisOFFSIDES
881ChondromalaciaOFFSIDES
882CirrhosisOFFSIDES
883Coagulation factor X level increasedOFFSIDES
884Contact DermatitisOFFSIDES
885Coronary angioplastyOFFSIDES
886Cytomegalovirus test positiveOFFSIDES
887Denervation atrophyOFFSIDES
888Dermatomycoses19659541CTD
889Diabetic RetinopathyOFFSIDES
890Diaphragmatic HerniaOFFSIDES
891DiverticulitisOFFSIDES
892Drug withdrawal headacheOFFSIDES
893Duodenal ulcer perforationCanada Vigilance: 1Canada Vigilance
894DysmenorrheaOFFSIDES
895Dysthymic DisorderOFFSIDES
896Ear and labyrinth disordersSIDER
897Eczema impetiginousOFFSIDES
898Endocardial diseaseOFFSIDES
899Enterococcal sepsisOFFSIDES
900Enterocolitis bacterialOFFSIDES
901Essential HypertensionOFFSIDES
902Exanthema18833041CTD
903Facial NeuralgiaOFFSIDES
904Fat intoleranceOFFSIDES
905Fat redistributionOFFSIDES
906Fatty LiverOFFSIDES
907Femoral artery occlusionOFFSIDES
908Fever18378354CTD
909Focal glomerulosclerosisOFFSIDES
910Free prostate-specific antigen increasedOFFSIDES
911Fungus serology test positiveOFFSIDES
912Gastric mucosal lesionOFFSIDES
913Gastrointestinal PainSIDER
914Gastrointestinal hypomotilityOFFSIDES
915Gastrointestinal mucosal disorderOFFSIDES
916General physical conditionOFFSIDES
917Glaucoma surgeryOFFSIDES
918GlobulinuriaOFFSIDES
919Glutamate dehydrogenase increasedOFFSIDES
920Grip strengthOFFSIDES
921Groin infectionOFFSIDES
922Haptoglobin DecreasedOFFSIDES
923Hay feverOFFSIDES
924Hepatitis A positiveOFFSIDES
925Hepatitis B DNA assay positiveCanada Vigilance: 1Canada Vigilance
926Hepatitis B antigen positiveCanada Vigilance: 1Canada Vigilance
927Hepatitis B positiveOFFSIDES
928Hepatitis B surface antigen positiveOFFSIDES
929Herpes simplex serology positiveOFFSIDES
930HiccoughOFFSIDES
931Histone antibody positiveOFFSIDES
932Horseshoe KidneyOFFSIDES
933Hyalohyphomycosis18415842CTD
934Incorrect route of product administrationCanada Vigilance: 1Canada Vigilance
935InfestationSIDER
936Infusion site mobility decreasedOFFSIDES
937Injection site discomfortOFFSIDES
938IntertrigoOFFSIDES
939Intra-aortic balloon placementOFFSIDES
940IridectomyOFFSIDES
941IritisOFFSIDES
942Klebsiella sepsisOFFSIDES
943LaryngospasmOFFSIDES
944Leukocyte alkaline phosphatase increasedOFFSIDES
945Leukopenia neonatalOFFSIDES
946LeukoplakiaOFFSIDES
947LightheadednessSIDER
948LipaseOFFSIDES
949Liver Cirrhosis20816994CTD
950Liver Failure, Acute17192859CTD
951Liver neoplasms25058030CTD
952Loss of personal independence in daily activitiesCanada Vigilance: 1Canada Vigilance
953Lumbar radiculopathyOFFSIDES
954Lung InjuryOFFSIDES
955Lupus ErythematosusSIDER
956LymphedemaOFFSIDES
957Malignant anorectal neoplasmOFFSIDES
958MastoiditisOFFSIDES
959Megakaryocytes increasedOFFSIDES
960Migraine with AuraOFFSIDES
961MononeuritisOFFSIDES
962Morganella infectionOFFSIDES
963Muscle SpasticityCanada Vigilance: 1Canada Vigilance
964Muscle abscessOFFSIDES
965Muscle strainOFFSIDES
966Mycoses12149384
17015631
23964828
CTD
967MyelodysplasiaOFFSIDES
968Nail discomfortCanada Vigilance: 1Canada Vigilance
969Nail pigmentationOFFSIDES
970NeurodermatitisOFFSIDES
971Optic Disc EdemaOFFSIDES
972Oropharyngeal plaqueOFFSIDES
973Oropharyngeal spasmOFFSIDES
974Otomycosis21895787
22359155
CTD
975PROTHROMBIN TIMEOFFSIDES
976ParakeratosisOFFSIDES
977Patellofemoral Pain SyndromeOFFSIDES
978Pelvic Floor Muscle WeaknessOFFSIDES
979Percutaneous Coronary InterventionOFFSIDES
980PeriarthritisOFFSIDES
981PericarditisOFFSIDES
982PharyngitisCanada Vigilance: 1Canada Vigilance
983Photosensitivity allergic reactionSIDER
984Physical disabilityOFFSIDES
985Postural Orthostatic Tachycardia SyndromeOFFSIDES
986Pregnancy on oral contraceptiveOFFSIDES
987Product contaminationOFFSIDES
988Prothrombin level abnormalOFFSIDES
989Prothrombin level decreasedOFFSIDES
990Psoriasis flare-upSIDER
991Red blood cell schistocytes presentOFFSIDES
992RednessSIDER
993Reticulocyte count decreasedOFFSIDES
994RetinitisOFFSIDES
995Schizoaffective DisorderOFFSIDES
996Schizotypal Personality DisorderOFFSIDES
997ScleritisOFFSIDES
998ScotomaOFFSIDES
SIDER
999Serum sickness-like reactionSIDER
1000Serum urea increasedSIDER
1001Silent myocardial infarctionOFFSIDES
1002Skin ErosionOFFSIDES
1003Skin texture abnormalCanada Vigilance: 1Canada Vigilance
1004Soft Tissue InjuriesOFFSIDES
1005Somatoform DisorderOFFSIDES
1006Spinal column stenosisOFFSIDES
1007Spinal shockOFFSIDES
1008StubbornnessOFFSIDES
1009Suprapubic painOFFSIDES
1010Suture insertionOFFSIDES
1011Systemic mycosisOFFSIDES
1012Taste Disorders10384922CTD
1013Thoracic vertebral fractureOFFSIDES
1014Tinea VersicolorOFFSIDES
1015Tinea17442600CTD
OFFSIDES
1016ToothacheSIDER
1017Traumatic liver injurySIDER
1018Vascular stenosisOFFSIDES
1019Vasculitic rashOFFSIDES
1020Vasculitis gastrointestinalSIDER
1021Venous stenosisOFFSIDES
1022Venous thrombosis limbOFFSIDES
1023Viral upper respiratory tract infectionCanada Vigilance: 1Canada Vigilance
1024Vitamin A DeficiencyOFFSIDES
1025Walking aid userOFFSIDES
1026carbuncleOFFSIDES
1027furuncleCanada Vigilance: 1Canada Vigilance
1028muscle injuryOFFSIDES
1029streptococcal serologyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.